HomeInsightsMarket Capitalization

Market Capitalization of Parenteral Drugs (india) Ltd

Market Capitalization of Parenteral Drugs (india) Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Aug 21, 2023)

stocks purchased

1.3 K

Stocks Traded

(Aug 21, 2023)

Last Updated on: Nov 24, 2024

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

Market Cap

₹ 10.11 crore

Last updated on: Aug 21, 2024

Key Highlights

  • The Market Cap of Parenteral Drugs (India) Ltd is ₹ 10.11 crore as of 21 Aug 23 .
  • The Market Cap of Parenteral Drugs (India) Ltd changed from ₹ 26.18 crore on March 2019 to ₹ 9.45 crore on March 2021 . This represents a CAGR of -28.80% over 3 years.
  • The Latest Trading Price of Parenteral Drugs (India) Ltd is ₹ 3.39 as of 21 Aug 15:30 .

Historical Market Cap of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Company Fundamentals for Parenteral Drugs (India) Ltd

No data available

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

Share Price

₹ 3.39

0.15 (4.63%)

stock direction

Last updated on: Aug 21, 2024

Market Price of Parenteral Drugs (India) Ltd

1M

1Y

3Y

5Y

Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20233.39
14 Aug 20233.24
24 Jul 20233.09
17 Jul 20233.25
10 Jul 20233.42
03 Jul 20233.59
26 Jun 20233.77
19 Jun 20233.96
12 Jun 20233.85
05 Jun 20234.05

SWOT Analysis Of Parenteral Drugs (India) Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Parenteral Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Parenteral Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Parenteral Drugs (India) Ltd

No data available

No data available

Historical P/E Ratio of Parenteral Drugs (India) Ltd

No data available

* All values are in %

Historical Revenue of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Parenteral Drugs (India) Ltd

  • Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company.
  • In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum.
  • In March 1994, the company was converted into a public limited company. Parenteral Drugs (India) is an India-based pharmaceutical company.
  • The Company manufactures, and markets pharmaceutical products in India, including solid and liquid orals, such as antibiotics and anti-bacterial, anti-ulcerant, analgesics/anti-inflammatory, multivitamins and minerals, anxiolyic , antiprotozoal, anticold, anthelmintic, anti-histaminic, muscle relaxant, cardiac, antidiabetic, cough syrup, appetite enhancer and injections. The Company produces various therapeutic segments of In-Vitro (I V) Fluids, such as electrolytes, antibacterial, energy replenisher, irrigation solution, osmotic diuretic, dialysis solution.

Parenteral Drugs (India) Ltd News Hub

News

Parenteral Drugs (India) to conduct board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 3...

Read more

19 May 202215:25

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

05 Feb 202215:19

News

Parenteral Drugs (India) to convene EGM

Parenteral Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Com...

Read more

03 Feb 202216:49

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 2...

Read more

31 Jan 202211:36

News

Parenteral Drugs (India) to hold board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

06 Nov 202116:34

News

Parenteral Drugs (India) AGM scheduled

Parenteral Drugs (India) announced that the 37th Annual General Meeting (AGM) of the compa...

Read more

27 Aug 202114:27

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Parenteral Drugs (India) Ltd Market Cap

What is the market cap of Parenteral Drugs (India) Ltd?

As of November 24, 2024, Parenteral Drugs (India) Ltd has a market capitalization of ₹10.11, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Parenteral Drugs (India) Ltd's market capitalization?

Parenteral Drugs (India) Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Parenteral Drugs (India) Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Parenteral Drugs (India) Ltd's market capitalization change?

Parenteral Drugs (India) Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*